Cost-effective carbohydrate synthesis permits large-scale production of an anti-inflammatory drug.
Sansom
C
C
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000138:chemical synthesis* / Q000191:economics / Q000627:therapeutic use; D002241:Carbohydrates / Q000138:chemical synthesis* / Q000191:economics / Q000627:therapeutic use; D017322:Clinical Trials, Phase II as Topic; D003362:Cost-Benefit Analysis; D006801:Humans; D007223:Infant; D015427:Reperfusion Injury / Q000188:drug therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002241:Carbohydrates